THE ROLE OF PEPSINOGENES AND SOME INTESTINAL HORMONES IN PATHOGENESIS OF GASTROESOPHAGEAL REFLUX DISEASE

Vira Boichuk

Abstract


80 patients with gastroesophageal reflux disease (GERD) were examined. The diagnosis of GERD was based on the history of the disease, complaints of patients, the results of daily monitoring of pH in the lower third of the esophagus, data of fibroesophagogastroduodenoscopy, chromoendoscopy, 13C-octanoic breath test, gastrin-17 (G-17) concentration, pepsinogens I and II (P I and II) and cholecystokinin-pancreozymin (C-P) in serum.

After 24 hours pH monitoring of the lower third of the esophagus in 40 patients with GERD, the predominance of acid was found, and the other 40 patients had mixed refluxes. In patients with predominance of acid reflux, the mean values of half-life of solid food evaluation (T1/2) according to 13C-octanoic breath test was (45.25±1.34) min. With the predominance of mixed refluxes in patients, there was a tendency towards hypokinetic motility of the stomach, indicating a slowdown in half-life of solid food evaluation from the stomach up to (139.24±11.87) min. With the predominance of acid reflux also was observed a significant reduction in the concentration of G-17 and C-P, an increase in P I and a decrease in the concentration of P II. Hypergastrinemia, high levels of C-P and P II (37.44±3.41) μg/l (p<0,05) were diagnosed with the predominance of mixed refluxes.

Keywords


gastroesophageal reflux disease; 24 hours pH monitoring of the lower third of the esophagus; 13C-octanoic breath test; gastropanel; cholecystokinin-pancreozymin

Full Text:

PDF

References


Aro, P., Ronkainen, J., Storskrubb, T., Bolling-Sternevald, E., Lind, T., Graffner, H. (2003). Quality of life in a general adult population with gastroesophageal reflux symptoms and/or esophagitis. A report from the Kalixanda study. Gastroenterology, 124 (4), 168–169. doi: 10.1016/s0016-5085(03)80835-1

Sobieraj, D. M., Coleman, S. M. (2011). US prevalense of upper gastrointestinal symptoms: a symptomatic literature review. American Journal of Managed Care, 17, 449–458.

Minatsuki, C., Yamamichi, N., Shimamoto, T., Kakimoto, H., Takahashi, Y., Fujishiro, M. et. al. (2013). Background Factors of Reflux Esophagitis and Non-Erosive Reflux Disease: A Cross-Sectional Study of 10,837 Subjects in Japan. PLoS ONE, 8 (7), e69891. doi: 10.1371/journal.pone.0069891

Kwiatek, M. A., Roman, S., Fareeduddin, A., Pandolfino, J. E., Kahrilas, P. J. (2011). An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial “acid pocket” in symptomatic GERD patients. Alimentary Pharmacology & Therapeutics, 34 (1), 59–66. doi: 10.1111/j.1365-2036.2011.04678.x

Dent, J., El-Serag, H. B., Wallander, M. A., Johansson, S. (2005). Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut, 54 (5), 710–717. doi: 10.1136/gut.2004.051821

Bredenoord, A. J., Weusten, B. L. A. M., Timmer, R., Smout, A. J. P. M. (2006). Air Swallowing, Belching, and Reflux in Patients with Gastroesophageal Reflux Disease. The American Journal of Gastroenterology, 101 (8), 1721–1726. doi: 10.1111/j.1572-0241.2006.00687.x

Yaylali, O., Kirac, S., Yilmaz, M., Akin, F., Yuksel, D., Demirkan, N., Akdag, B. (2009). Does Hypothyroidism Affect Gastrointestinal Motility? Gastroenterology Research and Practice, 2009, 1–7. doi: 10.1155/2009/529802

Sipponen, P., Vauhkonen, M., Helske, T. et. al. (2005). Low circulating levels of gastrin-17 in patients with Barrett’s esophagus. World Journal of Gastroenterology, 11 (38), 5988–5992. doi: 10.3748/wjg.v11.i38.5988

Pustorino, S., Calipari, G., Foti, M. et. al. (2002). Esophageal transit and esophageal motility disorders in patients with nontoxic goiter and recurrent dysphagia. Recenti Progressi in Medicina, 93 (4), 235–239.

Lundell, L. R., Dent, J., Bennett, J. R., Blum, A. L., Armstrong, D., Galmiche, J. P. et. al. (1999). Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut, 45 (2), 172–180. doi: 10.1136/gut.45.2.172

Roongruedee, C., Rungsun, R., Pinit, K. (2010). Role of digital chromoendoscopy in detecting minimal change esophageal reflux disease. World Journal of Gastrointestinal Endoscopy, 2 (4), 121–129. doi: 10.4253/wjge.v2.i4.121

Di Mario, F., Goni, E. (2015). A non-invasive approach to diagnosis of upper gastrointestinal diseases. Milan: AREA QUALITÀ S.r.l, 64.

Donald, O., Castell, M. D. (2013). Laryngopharyngeal Reflux To Be Or Not To Be? Journal of Clinical Gastroenterology, 47 (3), 193–194. doi: 10.1097/mcg.0b013e318279ac07

Igarashi, M., Nagano, J., Tsuda, A., Suzuki, T., Koike, J., Uchida, T. et. al. (2014). Correlation between the Serum Pepsinogen I Level and the Symptom Degree in Proton Pump Inhibitor-Users Administered with a Probiotic. Pharmaceuticals, 7 (7), 754–764. doi: 10.3390/ph7070754

Thomas, E., Wade, A., Crawford, G., Jenner, B., Levinson, N., Wilkinson, J. (2014). Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics, 39 (6), 595–602. doi: 10.1111/apt.12640

Hamdan, A.-L., Jabbour, J., Al Zaghal, Z., Azar, S. T. (2012). Goiter and Laryngopharyngeal Reflux. ISRN Endocrinology, 2012, 1–6. doi: 10.5402/2012/208958

Suzuki, H., Masaoha, T., Hoso da, H. et. al. (2006). Plasma ghrelin concentration correlates with the levels of serum pepsinogen T and pepsinogen I II ratio – a possible novel and noninvasive marker for gastric atrophy. Hepatogastroenterology, 51, 1249–1254.

Agreus, L., Storskrubb, T., Aro, P., Ronkainen, J., Talley, N. J., Sipponen, P. (2009). Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population. Scandinavian Journal of Gastroenterology, 44 (5), 564–570. doi: 10.1080/00365520902745062

Katz, P. O., Gerson, L. B., Vela, M. F. (2013). Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. The American Journal of Gastroenterology, 108 (3), 308–328. doi: 10.1038/ajg.2012.444

Nwokediuko, S. C. (2012). Current Trends in the Management of Gastroesophageal Reflux Disease: A Review. ISRN Gastroenterology, 2012, 1–11. doi: 10.5402/2012/391631




DOI: http://dx.doi.org/10.21303/2504-5679.2018.00538

Refbacks

  • There are currently no refbacks.




Copyright (c) 2018 Vira Boichuk

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)